Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IBDRY | PFE |
|---|---|---|
| Price | $94.33 | $27.41 |
| Change today | ▲ 0.55% | ▼ 1.40% |
| Market cap | $156.40B | $156.23B |
| Return, 3 months | -3.5% | +15.9% |
| Return, year to date | +9.2% | +15.8% |
| Return, 1 year | +24.5% | +11.0% |
| P/E (TTM) | 26.5 | 36.1 |
| P/B | 2.7 | 1.8 |
| P/E percentile vs own 5y | – | 93rd |
| Dividend yield | 3.34% | 6.28% |
| Revenue growth (YoY, latest qtr) | – | +2.6% |
| Net profit growth (YoY) | – | -108.1% |
| Gross margin | – | 73.2% |
| Operating margin | – | 26.7% |
| Net margin | – | 6.8% |
| Return on equity | – | 5.0% |
| Analyst target vs. price | – | +5.5% |
| Analyst buy share | – | 37% |
| RSI (14) | 54 | 42 |
| 30-day volatility | 13.9% | 16.1% |
| Max drawdown, 1 year | -9.2% | -15.7% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
